Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women
This study demonstrates that inhibiting the enzyme AKR1C3 selectively reduces the activation of 11-oxygenated androgens, but not classic androgens, in both systemic circulation and adipose tissue of women, offering a targeted therapeutic strategy for androgen excess conditions like PCOS.